default author photo

Gowri Chellappan

Inventprise Inc

SCHOLARLY PAPERS

2

DOWNLOADS

206

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Preclinical Immunogenicity Studies of Haemophilus influenzae type a Glycoconjugate Vaccine

Downloads 106 (664,543)

Preclinical Immunogenicity Studies of Haemophilus influenzae type a Glycoconjugate Vaccine

Number of pages: 19 Posted: 14 Nov 2025
Gowri Chellappan, Florence Seal, Winston Umakanth Balasundaram, Yutai Zhao, Giriraj Chalke, Shangdong Guo, Gowthami Jagruthi Penumaka, Geetha Karengil, Amandeep Grewal, Rashmi Ghayal, Jen Gan, Richa Puri, Dimple Reshma Machado, Aakriti Bajracharya, Pradip Ghate, Anup Datta and Subhash V. Kapre
Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc and Inventprise Inc
Downloads 60 (986,385)

Abstract:

Loading...

Hia, Indigenous communities, capsular polysaccharide, conjugate vaccine, hydrazide-polyethylene glycol-hydrazide linker, rCRM197, serum bactericidal antibody, Phase I clinical trials

Preclinical Immunogenicity Studies of Haemophilus influenzae type a Glycoconjugate Vaccine

Number of pages: 19 Posted: 14 Nov 2025
Gowri Chellappan, Florence Seal, Winston Umakanth Balasundaram, Yutai Zhao, Giriraj Chalke, Shangdong Guo, Gowthami Jagruthi Penumaka, Geetha Karengil, Amandeep Grewal, Rashmi Ghayal, Jen Gan, Richa Puri, Dimple Reshma Machado, Aakriti Bajracharya, Pradip Ghate, Anup Datta and Subhash V. Kapre
Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc, Inventprise Inc and Inventprise Inc
Downloads 46 (1,131,842)

Abstract:

Loading...

Hia, Indigenous communities, capsular polysaccharide, conjugate vaccine, hydrazide-polyethylene glycol-hydrazide linker, rCRM197, serum bactericidal antibody, Phase I clinical trials

2.

Sars-Cov-2 Conjugate Vaccine Elicits Robust Immune Responses that Can Protect Against Evolving Variants

Number of pages: 51 Posted: 18 Oct 2024
Melanie Carroll, Heather Fox, Anh Tran, Fataneh Karandish, Leonardo Rojas, Gowri Chellappan, Geetha Karengil, Brent Fall, Mary Whalen, John Langston, Michael J. McCluskie, Anup Datta, Subhash V. Kapre and Ivan A. Olave
Inventprise Inc, affiliation not provided to SSRN, National Research Council Canada, affiliation not provided to SSRN, affiliation not provided to SSRN, Inventprise Inc, Inventprise Inc, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, National Research Council Canada, Inventprise Inc, Inventprise Inc and affiliation not provided to SSRN
Downloads 100 (689,572)

Abstract:

Loading...

SARS-CoV-2, Coronavirus, Conjugate, Vaccines, Immunogenicity, Toll-like Receptors, Spike Protein, Variants of Concern.